Leading medical experts are increasingly pointing to diet and the body's insulin response as potential drivers behind a concerning rise in pancreatic cancer diagnoses among younger adults in the United States. While genetic factors play a role, a growing body of research suggests that modern lifestyle habits, particularly those involving high sugar intake, may be creating an environment conducive to the disease's development.
The theory centers on hyperinsulinemia, a condition characterized by persistently high levels of insulin in the blood. Normally, insulin helps cells absorb sugar from the bloodstream for energy. However, regular consumption of large amounts of sugar can force the body to produce more and more insulin. This excess insulin, scientists believe, may play a role in triggering pancreatic cancer.
Research from the University of British Columbia provided early evidence for this link. In experiments with mice, researchers observed that excessive insulin overstimulated pancreatic acinar cells, which produce digestive enzymes. This overstimulation led to premature activation of these enzymes, causing damage and inflammation within the pancreas. In mice with a common KRAS gene mutation, found in over 90% of human pancreatic cancers, this inflammatory environment appeared to promote the development of precancerous cells.
Further findings from the same research indicate that excess insulin might not only initiate pancreatic cancer but also fuel the growth of existing tumors. This suggests that dietary patterns leading to repeated spikes in blood sugar and insulin could be a contributing factor to the increasing rates of the disease.
These findings align with broader research linking diets high in ultra-processed foods to cancer. A comprehensive review of multiple studies indicated that individuals consuming the most ultra-processed foods had a significantly higher risk of developing cancer overall, with specific increases noted for colorectal, breast, and pancreatic cancers. One large U.S. study observed a 29% increased likelihood of colorectal cancer in men with the highest intake of ultra-processed foods.
Surgical oncologist Dr. Shanel Bhagwandin noted that chronically unhealthy diets can lead to obesity, insulin resistance, and diabetes, all of which are increasingly associated with pancreatic cancer. These conditions can foster widespread inflammation and bodily changes that may facilitate cancer development. Excess body fat, particularly abdominal fat, exacerbates insulin resistance through hormonal changes.
Statistics underscore these concerns. A 2025 analysis revealed that between 2000 and 2021, pancreatic cancer diagnoses among Americans aged 15 to 34 increased by 4.3% annually, and by 1.5% annually for those aged 35 to 54. While still rare in young adults, this sustained rise is a cause for concern among medical professionals.
Some cases occur in individuals who appear healthy and maintain a healthy lifestyle. Holly Shawyer, a marathon runner, was diagnosed at age 34 with a large tumor on her pancreas, initially mistaking her symptoms for a stomach ulcer. Similarly, Matthew Rosenblum was diagnosed at 32 with stage four pancreatic cancer, experiencing symptoms such as pale stools, rapid weight loss, and intense itching.
Experts emphasize that while there's no guaranteed way to prevent pancreatic cancer, certain lifestyle choices may reduce risk. Maintaining a healthy weight, managing blood sugar levels, and avoiding type 2 diabetes are considered beneficial. A Mediterranean-style diet, rich in healthy fats like oleic acid found in olive oil, nuts, and avocados, has also been suggested to be protective.
Doctors are also advised to be vigilant for subtle warning signs, especially in patients over 50 who suddenly develop diabetes. Unexplained weight loss, persistent abdominal or back pain, jaundice, diarrhea, and changes in stool color can be indicators that require prompt investigation. Recognizing when symptoms are unusual and seeking early medical evaluation is crucial for increasing the chances of detecting the cancer at a treatable stage.